Filing Details
- Accession Number:
- 0001437749-21-022183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-15 15:39:25
- Reporting Period:
- 2021-09-15
- Accepted Time:
- 2021-09-15 15:39:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
922247 | Cyclo Therapeutics Inc. | CYTH | Industrial Organic Chemicals (2860) | 593029743 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1163556 | Scott N Fine | 6714 Nw 16Th Street, Suite B Gainesville FL 32163 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-15 | 5,000 | $6.35 | 114,666 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $6.29 to $6.38, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.